ACTR-36. A SINGLE ARM PHASE 2 STUDY OF THE DUAL mTORC1/mTORC2 INHIBITOR VISTUSERTIB PROVIDED ON AN INTERMITTENT SCHEDULE FOR NEUROFIBROMATOSIS 2 PATIENTS WITH PROGRESSIVE OR SYMPTOMATIC MENINGIOMAS

Meningiomas are the second most common tumor in NF2 patients, with a cumulative prevalence of 80% by age 70 and a high prevalence of multiple meningiomas. Surgery remains standard of care for these tumors, yet outcomes remain suboptimal for many patients with multiple tumors. Loss of NF2 expression...

Full description

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Plotkin, Scott, Jordan, Justin, Beauchamp, Roberta, Muzikansky, Alona, Stemmer-Rachamimov, Anat, Ramesh, Vijaya
Format: Artigo
Language:Inglês
Published: Oxford University Press 2018
Subjects:
Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216352/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.069
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items